Switzerland to Loosen Restrictions on Medical Cannabis
On June 22, 2022, the Switzerland government announced the amendment to the Swiss Narcotics Act, which eases the ban on medical cannabis. Th…
Read more
Singapore HSA Updated the Guidance on Therapeutic Produ…
They revised checklists for post-approval minor variations (MIV-1 and MIV-2) with: Re-categorisation from MIV-2 Notification to MIV-2 Do-And…
Read more
Maldives Issued a Guideline on Registration of Nutraceu…
On 1 March 2022, The Maldives Food and Drug Authority (MFDA) issued a ‘Guideline on Registration of Nutraceuticals’. This guidel…
Read more
Australia TGA Updates Requirements for Medicinal Cannab…
In March 2022, TGA published details about the reforms to Medicinal Cannabis Products in Australia, it includes…
Read more
Philippines FDA Informs about Marketing Authorization o…
The Philippines FDA informs all establishments and stakeholders that…
Read more
Thailand to Partially Remove Cannabis from Illegal Narc…
Key Event Summary Thailand Public Health minister Anutin Charnvirakul signed a ministerial announcement, officially modified Category 5 of t…
Read more
New Version of the Australian Poisons Standard
The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP), commonly referred to as ‘The Poisons Standard’, is a legislati…
Read more
Australia: Changes to Vitamin B6 in Low-risk Medicines
The TGA is making changes to the maximum recommended daily dose of vitamin B6 permitted in Listed (low risk) medicines such as Complementary…
Read more
New Drug Traceability Code Printing Requirements in Chi…
On 21 June 2021, the Chinese National Medical Products Administration (NMPA) published two draft standards to clarify some of the requiremen…
Read more
BPOM published a new Guideline about Health Supplement …
New regulation about Health Supplement in Indonesia: BPOM published a new Guideline about Health Supplement and Traditional Medicine to moni…
Read more